Medicine composition for treating cerebral ischemia
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- GUIZHOU XINBANG YUANDONG PHARMACEUTICAL CO LTD
- Publication Date
- 2007-06-27
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
Technical field:
[0001] The invention relates to a compound composition with anti-cerebral ischemia effect, specifically, a combination of ginsenoside and salvianolic acid, which is an anti-cerebral ischemia drug, and belongs to the technical field of medicines. Background technique:
[0002] Cerebrovascular disease has the characteristics of high morbidity, disability, mortality and recurrence, and is one of the biggest killers threatening human health. According to epidemiological surveys, the incidence of cerebrovascular diseases worldwide is 1.4-200 / 100,000 population, and the average death rate is 100 / 100,000 population. With the aging of the population, cerebrovascular diseases, especially ischemic cerebrovascular diseases, have become one of the major diseases that threaten human health. It has brought a heavy burden and has attracted widespread attention from all countries in the world. The mortality rate of cerebrovascular disease in my country has jumped to the t...